High-content approaches to anthelmintic drug screening

de Moraes, 2020, FDA-approved antiparasitic drugs in the 21st century: a success for helminthiasis?, Trends Parasitol., 36, 573, 10.1016/j.pt.2020.04.005 Wolstenholme, 2004, Drug resistance in veterinary helminths, Trends Parasitol., 20, 469, 10.1016/j.pt.2004.07.010 Geary, 2015, Anthelmintic drug discovery: into the future, J. Parasitol., 101, 125, 10.1645/14-703.1 Nixon, 2020, Where are all the anthelmintics? Challenges and opportunities on the path to new anthelmintics, Int. J. Parasitol. Drugs Drug Resist., 14, 8, 10.1016/j.ijpddr.2020.07.001 Reimers, 2015, Drug-induced exposure of Schistosoma mansoni antigens SmCD59a and SmKK7, PLoS Negl. Trop. Dis., 9, 10.1371/journal.pntd.0003593 Panic, 2017, Immunohistochemical investigations of treatment with Ro 13-3978, praziquantel, oxamniquine, and mefloquine in Schistosoma mansoni-infected mice, Antimicrob. Agents Chemother., 61, 10.1128/AAC.01142-17 McCusker, 2021, Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure, PLoS Negl. Trop. Dis., 15, 10.1371/journal.pntd.0009200 Chan, 2017, The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand, Nat. Commun., 8, 1910, 10.1038/s41467-017-02084-0 Eyoh, 2019, The anthelmintic drug praziquantel promotes human Tr1 differentiation, Immunol. Cell Biol., 97, 512, 10.1111/imcb.12229 Moreno, 2010, Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi, Proc. Natl. Acad. Sci. U. S. A., 107, 20120, 10.1073/pnas.1011983107 Berrafato, 2019, Macrocyclic lactone anthelmintic-induced leukocyte binding to Dirofilaria immitis microfilariae: Influence of the drug resistance status of the parasite, Int. J. Parasitol. Drugs Drug Resist., 10, 45, 10.1016/j.ijpddr.2019.04.004 Martin, 2021, Ivermectin: an anthelmintic, an insecticide, and much more, Trends Parasitol., 37, 48, 10.1016/j.pt.2020.10.005 Hawking, 1948, Mode of action of hetrazan in filariasis, Lancet, 2, 730, 10.1016/S0140-6736(48)91165-9 Verma, 2020, Diethylcarbamazine activates TRP channels including TRP-2 in filaria, Brugia malayi, Commun. Biol., 3 Denham, 1978, Studies with Brugia pahangi 17. The anthelmintic effects of diethylcarbamazine, J. Parasitol., 64, 463, 10.2307/3279784 Cesbron, 1987, Platelets mediate the action of diethylcarbamazine on microfilariae, Nature, 325, 533, 10.1038/325533a0 McGarry, 2005, Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathway, Filaria J., 4, 4, 10.1186/1475-2883-4-4 Xiao, 2001, Artemether administered together with haemin damages schistosomes in vitro, Trans. R. Soc. Trop. Med. Hyg., 95, 67, 10.1016/S0035-9203(01)90336-0 Probst, 2020, Efficacy, metabolism and pharmacokinetics of Ro 15-5458, a forgotten schistosomicidal 9-acridanone hydrazone, J. Antimicrob. Chemother., 75, 2925, 10.1093/jac/dkaa247 Keiser, 2015, Aryl hydantoin Ro 13-3978, a broad-spectrum antischistosomal, J. Antimicrob. Chemother., 70, 1788, 10.1093/jac/dkv016 Pica-Mattoccia, 1989, Binding of oxamniquine to the DNA of schistosomes, Trans. R. Soc. Trop. Med. Hyg., 83, 373, 10.1016/0035-9203(89)90508-7 Nwaka, 2006, Innovative lead discovery strategies for tropical diseases, Nat. Rev. Drug Discov., 5, 941, 10.1038/nrd2144 Burns, 2015, Caenorhabditis elegans is a useful model for anthelmintic discovery, Nat. Commun., 6, 7485, 10.1038/ncomms8485 Burns, 2017, The novel nematicide wact-86 interacts with aldicarb to kill nematodes, PLoS Negl. Trop. Dis., 11, 10.1371/journal.pntd.0005502 Kamal, 2019, The marginal cells of the Caenorhabditis elegans pharynx scavenge cholesterol and other hydrophobic small molecules, Nat. Commun., 10, 3938, 10.1038/s41467-019-11908-0 Geary, 1999, Mechanism-based screening: discovery of the next generation of anthelmintics depends upon more basic research, Int. J. Parasitol., 29, 105, 10.1016/S0020-7519(98)00170-2 Elfawal, 2019, Drug screening for discovery of broad-spectrum agents for soil-transmitted nematodes, Sci. Rep., 9, 12347, 10.1038/s41598-019-48720-1 Mansour, 2016, High throughput screening identifies novel lead compounds with activity against larval, juvenile and adult Schistosoma mansoni, PLoS Negl. Trop. Dis., 10, 10.1371/journal.pntd.0004659 Guidi, 2017, Discovery by organism based high-throughput screening of new multi-stage compounds affecting Schistosoma mansoni viability, egg formation and production, PLoS Negl. Trop. Dis., 11, 10.1371/journal.pntd.0005994 Moffat, 2017, Opportunities and challenges in phenotypic drug discovery: an industry perspective, Nat. Rev. Drug Discov., 16, 531, 10.1038/nrd.2017.111 Voronin, 2019, Development of a preliminary in vitro drug screening assay based on a newly established culturing system for pre-adult fifth-stage Onchocerca volvulus worms, PLoS Negl. Trop. Dis., 13, 10.1371/journal.pntd.0007108 Malkmus, 2020, Preliminary evaluations of 3-dimensional human skin models for their ability to facilitate in vitro the long-term development of the debilitating obligatory human parasite Onchocerca volvulus, PLoS Negl. Trop. Dis., 14, 10.1371/journal.pntd.0008503 Feather, 2017, Ancylostoma ceylanicum infective third-stage larvae are activated by co-culture with HT-29-MTX intestinal epithelial cells, Parasit. Vectors, 10, 606, 10.1186/s13071-017-2513-x Duque-Correa, 2020, Organoids – new models for host–helminth interactions, Trends Parasitol., 36, 170, 10.1016/j.pt.2019.10.013 Vatta, 2014, Ivermectin-dependent attachment of neutrophils and peripheral blood mononuclear cells to Dirofilaria immitis microfilariae in vitro, Vet. Parasitol., 1–2, 38, 10.1016/j.vetpar.2014.02.004 Bulman, 2015, Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis, PLoS Negl. Trop. Dis., 9, 10.1371/journal.pntd.0003534 Keiser, 2016, Evaluation of an FDA approved library against laboratory models of human intestinal nematode infections, Parasit. Vectors, 9, 376, 10.1186/s13071-016-1616-0 Abdulla, 2009, Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening, PLoS Negl. Trop. Dis., 3, 10.1371/journal.pntd.0000478 Panic, 2015, Activity profile of an FDA-approved compound library against Schistosoma mansoni, PLoS Negl. Trop. Dis., 9, 10.1371/journal.pntd.0003962 Duguet, 2020, Identification of annotated bioactive molecules that impair motility of the blood fluke Schistosoma mansoni, Int. J. Parasitol. Drugs Drug Resist., 13, 73, 10.1016/j.ijpddr.2020.05.002 Spensley, 2018, Acute effects of drugs on Caenorhabditis elegans movement reveal complex responses and plasticity, G3, 8, 2941, 10.1534/g3.118.200374 Del Borrello, 2019, Rhodoquinone biosynthesis in C. elegans requires precursors generated by the kynurenine pathway, eLife, 8, 10.7554/eLife.48165 Mostafa, 2015, Transient effects of levamisole on Brugia malayi microfilariae, Invertebr. Neurosci., 15, 5, 10.1007/s10158-015-0181-0 Loghry, 2020, Ivermectin inhibits extracellular vesicle secretion from parasitic nematodes, J. Extracell. Vesicles, 10, 10.1002/jev2.12036 Moreno, 2021, When secretomes meet anthelmintics: Lessons for therapeutic interventions, Trends Parasitol., 37, 468, 10.1016/j.pt.2021.01.007 Jawahar, 2021, Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis, PLoS Negl. Trop. Dis., 15, 10.1371/journal.pntd.0009064 Chen, 2020, A multi-dimensional, time-lapse, high content screening platform applied to schistosomiasis drug discovery, Commun. Biol., 3, 747, 10.1038/s42003-020-01402-5 McDermott-Rouse, 2021, Behavioral fingerprints predict insecticide and anthelmintic mode of action, bioRxiv Gunderson, 2020, The endosymbiont Wolbachia rebounds following antibiotic treatment, PLoS Pathog., 16, 10.1371/journal.ppat.1008623 Jumani, 2019, A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors, Nat. Commun., 10, 1862, 10.1038/s41467-019-09880-w Abraham, 2020, Probing the Open Global Health Chemical Diversity Library for multistage-active starting points for next-generation antimalarials, ACS Infect. Dis., 6, 613, 10.1021/acsinfecdis.9b00482 Chandrasekaran, 2021, Image-based profiling for drug discovery: due for a machine-learning upgrade?, Nat. Rev. Drug Discov., 20, 145, 10.1038/s41573-020-00117-w Harischandra, 2018, Profiling extracellular vesicle release by the filarial nematode Brugia malayi reveals sex-specific differences in cargo and a sensitivity to ivermectin, PLoS Negl. Trop. Dis., 12, 10.1371/journal.pntd.0006438 James, 2007, A rapid colorimetric assay for the quantitation of the viability of free-living larvae of nematodes in vitro, Parasitol. Res., 101, 975, 10.1007/s00436-007-0572-1 Howe, 2015, Lactate as a novel quantitative measure of viability in Schistosoma mansoni drug sensitivity assays, Antimicrob. Agents Chemother., 59, 1193, 10.1128/AAC.03809-14 Lalli, 2015, Development and validation of a luminescence-based, medium-throughput assay for drug screening in Schistosoma mansoni, PLoS Negl. Trop. Dis., 9, 10.1371/journal.pntd.0003484 Aguiar, 2017, A high-throughput colorimetric assay for detection of Schistosoma mansoni viability based on the tetrazolium salt XTT, Parasit. Vectors, 10, 300, 10.1186/s13071-017-2240-3 Hovlid, 2016, Phenotypic screens in antimalarial drug discovery, Trends Parasitol., 32, 697, 10.1016/j.pt.2016.04.014 Babes, 2017, The anthelminthic drug praziquantel is a selective agonist of the sensory transient receptor potential melastatin type 8 channel, Toxicol. Appl. Pharmacol., 336, 55, 10.1016/j.taap.2017.10.012 Park, 2019, The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel, J. Biol. Chem., 294, 18873, 10.1074/jbc.AC119.011093 Swinney, 2011, How were new medicines discovered?, Nat. Rev. Drug Discov., 10, 507, 10.1038/nrd3480 International Helminth Genomes Consortium, 2019, Comparative genomics of the major parasitic worms, Nat. Genet., 51, 163, 10.1038/s41588-018-0262-1 Curran, 2020, Modeling the metabolic interplay between a parasitic worm and its bacterial endosymbiont allows the identification of novel drug targets, eLife, 9, 10.7554/eLife.51850 Bryant, 2018, A critical role for thermosensation in host seeking by skin-penetrating nematodes, Curr. Biol., 28, 2338, 10.1016/j.cub.2018.05.063 Lok, 2019, CRISPR/Cas9 mutagenesis and expression of dominant mutant transgenes as functional genomic approaches in parasitic nematodes, Front. Genet., 10, 656, 10.3389/fgene.2019.00656 Liu, 2020, In vivo imaging of transgenic Brugia malayi, PLoS Negl. Trop. Dis., 14, 10.1371/journal.pntd.0008182 Ittiprasert, 2019, Programmed genome editing of the omega-1 ribonuclease of the blood fluke, Schistosoma mansoni, eLife, 8, 10.7554/eLife.41337 Anderson, 2018, Genetic crosses and linkage mapping in schistosome parasites, Trends Parasitol., 34, 982, 10.1016/j.pt.2018.08.001 Doyle, 2019, Genome-wide approaches to investigate anthelmintic resistance, Trends Parasitol., 35, 289, 10.1016/j.pt.2019.01.004 Wit, 2021, Complementary approaches with free-living and parasitic nematodes to understanding anthelmintic resistance, Trends Parasitol., 37, 240, 10.1016/j.pt.2020.11.008 Hansen, 2017, Pathway of oxfendazole from the host into the worm: Trichuris suis in pigs, Int. J. Parasitol. Drugs Drug Resist., 7, 416, 10.1016/j.ijpddr.2017.11.002 Rottmann, 2010, Spiroindolones, a potent compound class for the treatment of malaria, Science, 329, 1175, 10.1126/science.1193225 Zhang, 2020, A marine microbiome antifungal targets urgent-threat drug-resistant fungi, Science, 370, 974, 10.1126/science.abd6919 Gao, 2019, A rotifer-derived paralytic compound prevents transmission of schistosomiasis to a mammalian host, PLoS Biol., 17, 10.1371/journal.pbio.3000485 Walker, 2017, Macrofilaricidal efficacy of repeated doses of ivermectin for the treatment of river blindness, Clin. Infect. Dis., 65, 2026, 10.1093/cid/cix616 Archer, 1985, The chemotherapy of schistosomiasis, Annu. Rev. Pharmacol. Toxicol., 25, 485, 10.1146/annurev.pa.25.040185.002413 Valentim, 2013, Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites, Science, 342, 1385, 10.1126/science.1243106 Nare, 1992, Mechanisms of inactivation of Schistosoma mansoni and mammalian glutathione S-transferase activity by the antischistosomal drug oltipraz, Biochem. Pharmacol., 43, 1345, 10.1016/0006-2952(92)90512-H Tracy, 1983, Reductive metabolism of niridazole by adult Schistosoma mansoni. Correlation with covalent drug binding to parasite macromolecules, Mol. Pharmacol., 24, 291 Wang, 2015, Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum, Nat. Commun., 6, 10111, 10.1038/ncomms10111